Early research (Phase 1)Study completedNCT04612062What this trial is testingA First-in-Human Study of CEE321 in Adult SubjectsWho this might be right forAtopic Dermatitis Novartis Pharmaceuticals 28
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Not applicableStudy completedNCT07009262What this trial is testingA Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE AttacksWho this might be right forHereditary Angioedema KalVista Pharmaceuticals, Ltd. 88
Early research (Phase 1)Looking for participantsNCT07247266What this trial is testingStudy to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)Who this might be right forCryopyrin-associated Periodic Syndromes (CAPS) Akros Pharma Inc. 5
Post-approval studies (Phase 4)Ended earlyNCT00418821What this trial is testingThe Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed InfantsWho this might be right forMucopolysaccharidosis IHurler's SyndromeHurler-Scheie Syndrome+1 more Genzyme, a Sanofi Company 2
Very early researchWithdrawnNCT03921515What this trial is testingSkin Immunity Sample Collection Involving Blisters and BiopsiesWho this might be right forHyper-Immunoglobulin E. Syndrome (HEIS)Chronic Granulomatous Disease (CGD) National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Looking for participantsNCT07277660What this trial is testingA Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis UCB Biopharma SRL 160
Not applicableStudy completedNCT00616096What this trial is testingStudy of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE LevelsWho this might be right forDermatitis, Atopic University of Luebeck 10
Not applicableActive Not RecruitingNCT01782703What this trial is testingDefining the Skin and Blood Biomarkers of Pediatric Atopic DermatitisWho this might be right forAtopic DermatitisEczema Northwestern University 505
Not applicableNot Yet RecruitingNCT05848856What this trial is testingThe RISC Registry--Risk Informed Screening RegistryWho this might be right forBreast Cancer RiskCardiovascular Disease RiskCardiometabolic Risk+1 more Precision Health Equity Initiative 10,000
Post-approval studies (Phase 4)UnknownNCT05578482What this trial is testingStaphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic DermatitisWho this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Dermatitis Flare Jacob Pontoppidan Thyssen 45
Post-approval studies (Phase 4)Ended earlyNCT00810862What this trial is testingStudy of Pimecrolimus Treatment for Atopic Dermatitis of African American ChildrenWho this might be right forAtopic Dermatitis Children's Hospital of Michigan 18
Large-scale testing (Phase 3)WithdrawnNCT01125761What this trial is testingEfficacy and Safety of the Association Drugs in Patients With Allergic DermatitisWho this might be right forDermatitis Azidus Brasil
Not applicableStudy completedNCT05519124What this trial is testingBTL-785F Device for Non-invasive Reduction of WrinklesWho this might be right forWrinkle BTL Industries Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01538862What this trial is testingEfficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis BullosaWho this might be right forDystrophic Epidermolysis Bullosa Vanderbilt University Medical Center 7
Large-scale testing (Phase 3)Study completedNCT03297502What this trial is testingSafety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Par Pharmaceutical, Inc. 582
Large-scale testing (Phase 3)Study completedNCT04687137What this trial is testingExpanded Access Program With Lanadelumab for Japanese People With Hereditary AngioedemaWho this might be right forHereditary Angioedema Takeda 12
Not applicableUnknownNCT00006393What this trial is testingGenetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisWho this might be right forSystemic Sclerosis National Center for Research Resources (NCRR) 80
Not applicableUnknownNCT04258735What this trial is testingGenetic Characteristics of Metastatic Breast Cancer PatientsWho this might be right forMetastatic Breast Cancer Samsung Medical Center 300
Not applicableStudy completedNCT04641325What this trial is testingMarfan Syndrome Moderate Exercise PilotWho this might be right forMarfan Syndrome Baylor College of Medicine 23